Results 81 to 90 of about 37,722 (251)

Antithrombin III Regulates Complement Activity

open access: yes, 1991
Journal of Immunology, 146, 3889-3894Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY.
Linhardt, Robert J., Weiler, J.M.
core  

Impact of Treatment Response to Anticoagulant Therapy on Liver‐Related Events in Patients With Cirrhosis and Portal Vein Thrombosis

open access: yesHepatology Research, EarlyView.
In patients with cirrhosis and a first portal vein thrombosis treated with intravenous anticoagulant therapy, the 3‐year cumulative rates of liver‐related events were 56.7% and 75.5% in the effective and ineffective groups, respectively. A good radiological response was associated with fewer liver‐related hospitalizations.
Atsushi Maeda   +19 more
wiley   +1 more source

Properties of Antithrombin II Its Distinctions From Antithrombin III, and Its Role in Thrombo-Embolic Conditions

open access: yes, 1969
The necessity of a co-factor for the antithrombic effect of heparin is a relatively well established fact. There is, however, still a considerable amount of discussion about the properties of this co-factor (antithrombin II), and its relation to ...
Moylan, Mary Harold
core  

Antithrombin as Substrate for the Enzyme Thrombin

open access: yes, 1960
SummaryIn the interaction of thrombin (Th) and antithrombin (A) the activity of both is temporarily neutralized. Later thrombin activity regenerates and antithrombin is altered (P). Thrombin inactivates antithrombin.
Walter H. Seegers   +2 more
core   +1 more source

Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE

open access: yesInternational Journal of General Medicine, 2021
Yu-Yan Wu,* Yong Tan,* Min Yan, Zhen Cheng, Xiang-Tao Pan Department of Hematology, Taicang Hospital of Soochow University, Taicang, Jiangsu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiang-Tao ...
Wu YY, Tan Y, Yan M, Cheng Z, Pan XT
doaj  

Nanoparticles in Periodontology and Implant Dentistry: From Mechanisms to Clinical Applications

open access: yesJournal of Periodontal Research, EarlyView.
Nanotechnology holds significant promise in improving dental care, yet there is a need for more reliable clinical studies to validate its effectiveness and safety. ABSTRACT Recent advances in nanotechnology are reshaping the landscape of periodontology and implant dentistry, particularly through the application of nanoparticles (NPs).
Chun Xu   +4 more
wiley   +1 more source

Ribbon diagram of antithrombin.

open access: yes, 2014
A) Structural representation of the localization of N135 (red spheres) in native antithrombin (PDB code 1T1FA). Strand 2A and helix D are displayed in cyan.
Irene Martínez-Martínez (355122)   +6 more
core   +1 more source

Efficacy of antithrombin administration for patients with sepsis: A systematic review, meta‐analysis, and meta‐regression

open access: yesAcute Medicine & Surgery
Aims There have been inconsistent reports regarding the effect of antithrombin on sepsis; furthermore, there are limited reports on how dosage affects therapeutic efficacy.
Takumi Tsuchida   +10 more
doaj   +1 more source

Complement–Eosinophil Crosstalk Links Complement Activation to Fibrin Deposition in Eosinophilic Chronic Rhinosinusitis

open access: yes
Allergy, EarlyView.
Ryo Hasegawa   +18 more
wiley   +1 more source

Transfusion of blood products to neonatal and pediatric extracorporeal membrane oxygenation patients: A prospective, observational study

open access: yesTransfusion, EarlyView.
Abstract Study Question To describe the blood product utilization during neonatal and pediatric extracorporeal membrane oxygenation (ECMO) and to determine whether its usage correlates with clinical outcomes of bleeding, thrombosis or mortality. Design Prospective observational study of neonatal and pediatric ECMO patients from September 2016, until ...
Rebecca Barton   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy